Variables | 3D group (30 cases) | CTA group (30 cases) | p value |
---|---|---|---|
Gender, n (%) | 0.774 | ||
Male | 22 (73.3) | 21 (70) | |
Female | 8 (26.7) | 9 (30) | |
Age (years, mean ± SD) | 57.6 ± 11.7 | 56.4 ± 9.8 | 0.669 |
BMI (mean ± SD) | 25.2 ± 2.8 | 24.9 ± 2.5 | 0.622 |
Tumor size (cm, median) | 4.0 | 3.75 | 0.082 |
Operative time (min, mean ± SD) | 125.4 ± 19.7 | 136.6 ± 15.1 | 0.017 |
Estimated blood loss (ml, mean ± SD) | 130.3 ± 39.9 | 179.0 ± 77.2 | 0.003 |
Hospital stay (days, mean ± SD) | 5.0 ± 1.1 | 5.4 ± 1.0 | 0.114 |
Pathologic subtype, n (%) | 0.543 | ||
Clear cell | 26 (86.7) | 25 (83.3) | |
Chromophobe | 1 (3.3) | 3 (10) | |
Papillary | 3 (10) | 2 (6.7) | |
Furhman grade, n (%) | 0.740 | ||
I | 10 (33.3) | 12 (40) | |
II | 16 (53.4) | 13 (43.3) | |
III | 4 (13.3) | 5 (16.7) | |
Complications, n (%) | 0.365 | ||
Fever | 1 (3.3%) | 0 | |
Hematuria | 1 (3.3) | 3 (10%) | |
eGFR change (ml/min/1.73m2, mean ± SD) | −8.67 ± 8.8 | −10.6 ± 11.5 | 0.459 |